Skip to main content
. 2022 May;14(5):1696–1712. doi: 10.21037/jtd-21-1502

Table 2. MD Anderson criteria for evaluation of response in bone metastases.

Response type Definition
Complete response Complete fill-in or sclerosis of lytic lesion on CT or XR
Disappearance of tumor signal on bone scan, CT, or MRI
Normalization of osteoblastic lesion on CT or XR
Partial response Sclerotic rim formation around initially lytic lesion on CT
Sclerosis of lesions previously undetected on CT or XR
Partial fill-in or sclerosis of lytic lesion on CT or XR
Regression of measurable lesion on CT, MRI, or XR
Regression of lesion on bone scan
Decrease in blastic lesion on CT or XR
Stable disease No change in measurable lesion on CT, MRI, or XR
No change in blastic or lytic lesion or CT, MRI, or XR
No new lesion on CT, MRI, or XR
Progressive disease Increase in size of existing measurable lesion on CT, MRI, or XR
New lesion on CT, MRI, bone scan, or XR
Increase in lytic or blastic lesion on CT or XR

Ct, computed tomography; xr, plain radiography; Mri, magnetic resonance imaging. Adopted with publisher permission from (129).